z-logo
open-access-imgOpen Access
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy individuals: results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Author(s) -
Leonardo Santos Hoff,
Samuel Katsuyuki Shinjo,
R Naveen,
Jessica Day,
Parikshit Sen,
Jucier Gonçalves Júnior,
James B Lilleker,
Mrudula Joshi,
Vishwesh Agarwal,
Sinan Kardeş,
MinChul Kim,
Marcin Milchert,
Ashima Makol,
Tamer A. Gheita,
Babur Salim,
Tsvetelina Velikova,
Abraham Edgar GraciaRamos,
Ioannis Parodis,
Albert Selva-O’Callaghan,
Eleikiphorou,
Ai Lyn Tan,
Tulika Chatterjee,
Lorenzo Cavagna,
Miguel Ángel Saavedra,
Nelly Ziadé,
Johannes Knitza,
Masataka Kuwana,
Arvind Nune,
Oliver Distler,
Hector Chinoy,
Vikas Agarwal,
Rohit Aggarwal,
Latika Gupta,
COVAD Study Group
Publication year - 2022
Publication title -
xxxix congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2022.1905
Subject(s) - medicine , covid-19 , vaccination , immunology , virology , disease , outbreak , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom